• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四种三环类抗抑郁药物与人腮腺中毒蕈碱胆碱能受体的结合亲和力。

Binding affinities of four tricyclic antidepressive drugs to muscarinic cholinergic receptors in human parotid gland.

作者信息

Batra S, Biörklund A

出版信息

Psychopharmacology (Berl). 1986;90(1):1-4. doi: 10.1007/BF00172861.

DOI:10.1007/BF00172861
PMID:3094050
Abstract

The binding kinetics of tritiated quinuclidinyl benzilate (QNB) were studied in membrane preparations from human parotid and rabbit submandibular glands. Inhibition of 3H-QNB was then used to compare the anticholinergic activity of lofepramine, desipramine, imipramine and amitriptyline for muscarinic receptor in the salivary glands. The apparent dissociation constant (KD) for 3H-QNB binding in human parotid and rabbit submandibular gland was 33 and 61 pM and the Bmax value 507 and 169 f mol/mg protein, respectively. The mean values for the inhibition constant (Ki) for lofepramine, desipramine, imipramine and amitriptyline in human parotid gland were 285, 135, 102 and 13 nM, respectively. Very similar values were obtained for the rabbit submandibular gland. The binding affinity of tricyclic antidepressants for muscarinic cholinergic receptor sites in human parotid gland closely paralleled clinical data on the inhibition of salivary flow by these drugs.

摘要

在人腮腺和兔下颌下腺的膜制剂中研究了氚化苄哌苯胺(QNB)的结合动力学。然后利用3H-QNB抑制作用比较了洛非帕明、地昔帕明、丙咪嗪和阿米替林对唾液腺毒蕈碱受体的抗胆碱能活性。人腮腺和兔下颌下腺中3H-QNB结合的表观解离常数(KD)分别为33和61 pM,Bmax值分别为507和169 fmol/mg蛋白。洛非帕明、地昔帕明、丙咪嗪和阿米替林在人腮腺中的抑制常数(Ki)平均值分别为285、135、102和13 nM。兔下颌下腺也得到了非常相似的值。三环类抗抑郁药对人腮腺毒蕈碱胆碱能受体位点的结合亲和力与这些药物抑制唾液分泌的临床数据密切相关。

相似文献

1
Binding affinities of four tricyclic antidepressive drugs to muscarinic cholinergic receptors in human parotid gland.四种三环类抗抑郁药物与人腮腺中毒蕈碱胆碱能受体的结合亲和力。
Psychopharmacology (Berl). 1986;90(1):1-4. doi: 10.1007/BF00172861.
2
Identification and characterization of muscarinic cholinergic receptors in the human urinary bladder and parotid gland.人膀胱和腮腺中毒蕈碱型胆碱能受体的鉴定与特性研究
J Auton Nerv Syst. 1987 Aug;20(2):129-35. doi: 10.1016/0165-1838(87)90110-x.
3
Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum.腮腺中的毒蕈碱受体结合。某些抗胆碱能药物在腮腺和回肠之间的不同亲和力。
Scand J Gastroenterol Suppl. 1982;72:69-77.
4
Comparison of muscarinic acetylcholine binding in the urinary bladder and submandibular gland of the rabbit.兔膀胱与颌下腺中毒蕈碱型乙酰胆碱结合情况的比较。
Eur J Pharmacol. 1987 Jun 12;138(1):83-8. doi: 10.1016/0014-2999(87)90340-2.
5
High affinity quinuclidinyl benzilate binding to rat parotid membranes requires muscarinic receptor. G protein interactions.高亲和力的二苯羟乙酸奎宁环酯与大鼠腮腺膜结合需要毒蕈碱受体。G蛋白相互作用。
FEBS Lett. 1991 May 6;282(2):289-92. doi: 10.1016/0014-5793(91)80497-q.
6
Characterization of muscarinic cholinergic receptors in the submandibular gland of the rat.大鼠下颌下腺中毒蕈碱型胆碱能受体的特性研究
J Auton Nerv Syst. 1985 Aug;13(4):287-301. doi: 10.1016/0165-1838(85)90018-9.
7
On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.关于膀胱中的毒蕈碱受体以及毒蕈碱受体的假定亚分类
Acta Pharmacol Toxicol (Copenh). 1986;59 Suppl 1:1-45.
8
A comparative study of the affinities of some tricyclic antidepressants for the muscarinic cholinergic receptor in human and guinea-pig bladder, ileum and brain in relation to differential drug potency.
Life Sci. 1987 May 4;40(18):1819-27. doi: 10.1016/0024-3205(87)90093-2.
9
Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.犬门静脉中毒蕈碱型胆碱能受体的证据:[3H]喹核醇基苯甲酸酯的结合
Life Sci. 1983 Apr 11;32(15):1757-63. doi: 10.1016/0024-3205(83)90839-1.
10
Sphingosine inhibits muscarinic cholinergic receptor binding in rat parotid acinar cells.鞘氨醇抑制大鼠腮腺腺泡细胞中毒蕈碱胆碱能受体结合。
Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992 Oct;103(2):269-72.

引用本文的文献

1
Functional reactivity of central cholinergic systems following desipramine treatments and sleep deprivation.地昔帕明治疗和睡眠剥夺后中枢胆碱能系统的功能反应性
Naunyn Schmiedebergs Arch Pharmacol. 2003 Oct;368(4):294-300. doi: 10.1007/s00210-003-0784-6. Epub 2003 Sep 11.
2
Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
Drugs. 1989 Feb;37(2):123-40. doi: 10.2165/00003495-198937020-00003.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
The pharmacological profile of lofepramine, a new antidepressant drug.新型抗抑郁药物洛非帕明的药理学概况。
Neuropharmacology. 1980 Dec;19(12):1213-4. doi: 10.1016/0028-3908(80)90206-3.
3
The effect of five tricyclic antidepressants on salivary flow and mood in healthy volunteers.
Commun Psychopharmacol. 1980;4(4):255-61.
4
The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors.某些抗抑郁药物与脑内毒蕈碱型乙酰胆碱受体的结合。
Br J Pharmacol. 1980 Mar;68(3):541-9. doi: 10.1111/j.1476-5381.1980.tb14570.x.
5
Comparison of peripheral anticholinergic effects of antidepressants: dry mouth.
Acta Psychiatr Scand Suppl. 1981;290:364-9. doi: 10.1111/j.1600-0447.1981.tb00741.x.
6
Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.毒蕈碱受体亚型:M1和M2的生化及功能特性
Life Sci. 1982 Dec 27;31(26):2991-8. doi: 10.1016/0024-3205(82)90066-2.
7
[3H]oxotremorine-M binding to membranes prepared from rat brain and heart: evidence for subtypes of muscarinic receptors.[3H]氧代震颤素-M与大鼠脑和心脏制备的膜的结合:毒蕈碱受体亚型的证据。
Eur J Pharmacol. 1984 May 18;101(1-2):101-10. doi: 10.1016/0014-2999(84)90035-9.
8
Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain.抗抑郁药对人脑海马胆碱能乙酰胆碱受体的拮抗作用。
Br J Pharmacol. 1983 Jan;78(1):97-102.
9
Effects of antidepressant drugs on different receptors in the brain.抗抑郁药物对大脑中不同受体的影响。
Eur J Pharmacol. 1981 Mar 26;70(3):393-407. doi: 10.1016/0014-2999(81)90172-2.
10
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.抑制常数(K1)与导致酶促反应50%抑制率(I50)的抑制剂浓度之间的关系。
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108. doi: 10.1016/0006-2952(73)90196-2.